BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Genetown

  SCIEX Launches OptiFlow Quant Solution for BioPharma Peptide Quantitation

  Solution offers researchers increased sensitivity without sacrificing robustness or usability

  February 26, 2018

   · 

  4 min read
• BioMidwest

  BIO Selects Des Moines as Venue for the 2019 BIO World Congress on Industrial Biotechnology

  The Biotechnology Innovation Organization (BIO) today announced the selection of Des Moines, Iowa, as the location for the 2019 BIO World Congress on Industrial Biotechnology.

  February 26, 2018

   · 

  3 min read
• RenovaCare Issues Important Shareholder Update Following Patent Win and FDA News

  RenovaCare, Inc., (RCAR), developer of the SkinGun™ and CellMist™ System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, today announced new initiatives to expand its product pipeline and associated clinical indications beyond severe second-degree burns.

  February 26, 2018

   · 

  8 min read
• Business

  InDex Pharmaceuticals Holding AB (publ) Year end Report 2017

  “The patient recruitment in the CONDUCT study is developing as expected and our objective to report top line results from the study in the fourth quarter of 2018 remains,” said Peter Zerhouni, CEO of InDex Pharmaceuticals.

  February 26, 2018

   · 

  5 min read
• Business

  Minerva Biotechnologies Announces CellSystems as European Distributor of AlphaSTEM™, Naïve Stem Cell Culture System

  Minerva Biotechnologies Corporation, a leading cancer immunotherapy and regenerative medicine company, announces European distribution agreement with CellSystems Biotechnologie Vertrieb a major European life science supplier, for AlphaSTEM™ Naïve Stem Cell Culture System.

  February 26, 2018

   · 

  2 min read
• Drug Development

  TWi Biotechnology, Inc. Announced Regulatory Clearance to Begin Phase 2 Proof-of-Concept Clinical trial of AC-203 for treatment of Inherited Epidermolysis Bullosa

  This trial is designed to be a double-blind, intra-individual comparison, proof-of-concept clinical trial, and will enroll patients as young as 2 year old.

  February 26, 2018

   · 

  4 min read
• Business

  NovellusDx to perform retrospective analysis of the MOST clinical trial to test the predictive ability of its functional assay in cancer patients.

  Centre Léon-Bérard and the biotechnology company NovellusDx are collaborating on a retrospective analysis of two study arms of the MOST trial.

  February 26, 2018

   · 

  2 min read
• Business

  Themis Establishes Scientific Advisory Board of Experts in Virology and Vaccine Development

  The purpose of the SAB will be to advise Themis as it continues to develop its pipeline of urgently needed vaccines and immune system activation approaches.

  February 26, 2018

   · 

  5 min read
• Business

  West Appoints Silji Abraham Chief Digital and Transformation Officer

  Mr. Abraham will serve on the senior leadership team, and oversee the Company’s Information Technology (IT) and Enterprise Business Systems organizations

  February 26, 2018

   · 

  2 min read
• BioMidwest

  More than 1 Million Screened for Colorectal Cancer with Cologuard

  Noninvasive test is changing how Americans get checked for the most preventable form of cancer.

  February 26, 2018

   · 

  4 min read